Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


ViroPharma, Inc.

ViroPharma Incorporated is a multinational biotechnology company committed to developing and commercializing innovative products that address unmet medical needs. Their current focus is to develop products for physician specialists that support patients with serious diseases caused by CMV, C. difficile, and hereditary angioedema.

Search Projects

  • Head, Commercial Manufacturing
  • Project Leader